简介:A 484954是真核延长因子 2 (eEF2) 的高度选择性抑制剂,其 IC50 值为 280 nM。
A 484954物理化学性质:
密度 |
1.522±0.06 g/cm3 (20 ºC 760 Torr) |
分子式 |
C13H15N5O3 |
分子量 |
289.29 |
精确质量 |
289.117 |
PSA |
127.72 |
LogP |
0.4084 |
外观性状 |
white to beige |
储存条件 |
2-8°C |
水溶解性 |
DMSO: soluble 3mg/mL, clear (warmed) |
A 484954详细介绍:
中文名称: |
7-氨基-1-环丙基-3-乙基-2,4-二氧代吡啶并[2,3-d]嘧啶-6-羧酰胺 |
中文别名: |
7-氨基-1-环丙基-3-乙基-1,2,3,4-四氢-2,4-二氧代-吡啶并[2,3-D]嘧啶-6-甲酰胺;7-氨基-1-环丙基-3-乙基-2,4-二酮代吡啶并[2,3-d]嘧啶-6-甲酰胺;7-氨基-1-环丙基-3-乙基-2,4-二氧代吡啶并[2,3-d]嘧啶-6-羧酰胺 |
英文名称: |
A 484954 |
英文别名: |
Pyrido[2,3-d]pyrimidine-6-carboxamide, 7-amino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dioxo-;7-Amino-1-cyclopropyl-3-ethyl-2,4-dioxopyrido[2,3-d]pyrimidine-6-carboxamide;7-Amino-1-cyclopropyl-3-ethyl-2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidine-6-carboxamide;A 484954;A-484954;Pyrido[2,3-d]pyrimidine-6-carboxamide,7-amino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dio...;Pyrido[2,3-d]pyrimidine-6-carboxamide,7-amino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dioxo-;7-AMino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dioxopyrido[2,3-d]pyriMidine-6-carboxaMide;Kinome_3822;X5939;7-Amino-1-cyclopropyl-3-ethyl-1,2,3,4-tetrahydro-2,4-dioxo-pyrido[2,3-d]pyrimidine-6-carboxamideddd |
CAS号: |
142557-61-7 |
分子式: |
C13N5O3H15 |
分子量: |
289.29 |
详细描述 |
博飞美科提供142557-61-7,A 484954,Medlife,上海现货。Medlife,致力于提供高品质、高性价比小分子化合物的产品。Medlife小分子化合物大量库存,提供超过2万种的抑制剂、激动剂、拮抗剂等产品,是药物及疾病研究的重要原料供应商。真核延伸因子-2(eEF-2)激酶抑制剂,A-484954 是真核延长因子 2 (eEF2) 的高度选择性抑制剂,其 IC50 值为 280 nM。 查询关键词:“142557-61-7,A 484954,PC15089,Medlife,上海现货”。 |
A 484954参考文献:
[1]. Chen Z, et al. 1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) induces phosphorylation of eukaryotic elongation factor-2 (eEF2): a cautionary note on the anticancer mechanism of an eEF2 kinase inhibitor. J Biol Chem. 2011 Dec 23;286(51):43951-8.
[2]. Kodama T, et al. Mechanisms underlying the relaxation by A484954, a eukaryotic elongation factor 2 kinase inhibitor, in rat isolated mesenteric artery. J Pharmacol Sci. 2018 May;137(1):86-92.
[3]. Kameshima S, et al. Eukaryotic elongation factor 2 kinase mediates monocrotaline-induced pulmonary arterial hypertension via reactive oxygen species-dependent vascular remodeling. Am J Physiol Heart Circ Physiol. 2015 May 15;308(10):H1298-305.
产品技术规格说明书由上海创赛科技有限公司收集整理,仅作参考使用。